Pricing Log in Create free account

CAMP4 Therapeutics Corporation (CAMP) vs Zentalis Pharmaceuticals, Inc. (ZNTL)

CAMP4 Therapeutics Corporation and Zentalis Pharmaceuticals, Inc. are both Biotechnology companies. CAMP4 Therapeutics Corporation and Zentalis Pharmaceuticals, Inc. are of similar size ($216.5M and $212.1M). Zentalis Pharmaceuticals, Inc. has the higher net margin (0.00% vs −2,543.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Zentalis Pharmaceuticals, Inc. leads on 7 and CAMP4 Therapeutics Corporation on 4.

Valuation

Metric CAMP ZNTL Biotechnology median
P/E n/m n/m 8.42
P/S 47.40 n/m 10.01
P/B n/m 1.12 2.21
Price to free cash flow n/m n/m 21.01
EV/EBITDA n/m 0.09 0.61
EV/Sales 26.75 n/m 9.41
Earnings yield (67.25%) (86.67%) (31.85%)
Free cash flow yield (14.35%) (79.76%) (24.58%)

Profitability

Metric CAMP ZNTL Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (1,254.22%) 0.00% 0.00%
Net margin (2,543.74%) 0.00% 0.00%
Free cash flow margin (680.36%) 0.00% 0.00%
Return on equity (545.85%) (66.75%) (56.36%)
Return on assets (148.23%) (49.22%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CAMP ZNTL Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 76.00% 18.03% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CAMP ZNTL Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.70 4.82 4.72
Net debt to EBITDA 2.18 1.59 0.96

Dividend

Metric CAMP ZNTL Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric CAMP ZNTL Biotechnology median
Market cap 216.50m 212.07m 132.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack